[1]
|
Green, M. and Loewenstein, P.M. (1988) Autonomous Functional Domains of Chemically Synthesized Human Immunodeficiency Virus Tat Trans-Activator Protein. Cell, 55, 1179-1188.
https://doi.org/10.1016/0092-8674(88)90262-0
|
[2]
|
Vives, E., Brodin, P. and Lebleu, B. (1997) A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Nucleus. The Journal of Biological Chemistry, 272, 16010-16017. https://doi.org/10.1074/jbc.272.25.16010
|
[3]
|
Milletti, F. (2012) Cell-Penetrating Peptides Classes, Origin and Current Landscape. Drug Discovery Today, 17, 850-860. https://doi.org/10.1016/j.drudis.2012.03.002
|
[4]
|
Tunnemann, G., Ter-Avetisyan, G., Martin, R.M., et al. (2008) Live-Cell Analysis of Cell Penetration Ability and Toxicity of Oligo-Arginines. Journal of Peptide Science, 14, 469-476. https://doi.org/10.1002/psc.968
|
[5]
|
Futaki, S., Suzuki, T., Ohashi, W., et al. (2001) Arginine-Rich Peptides. An Abundant Source of Membrane Permeable Peptides Having Potential as Carriers for Intracellular Protein Delivery. The Journal of Biological Chemistry, 276, 5836-5840. https://doi.org/10.1074/jbc.M007540200
|
[6]
|
Prochiantz, A. (1996) Getting Hydrophilic Compounds into Cells: Lessons from Homeopeptides. Current Opinion in Neurobiology, 6, 629-634. https://doi.org/10.1016/S0959-4388(96)80095-X
|
[7]
|
Mueller, J., Kretzschmar, I., Volkmer, R., et al. (2008) Comparison of Cellular Uptake Using 22 CPPs in 4 Different Cell Lines. Bioconjugate Chemistry, 19, 2363-2374. https://doi.org/10.1021/bc800194e
|
[8]
|
Oehlke, J., Krause, E., Wiesner, B., et al. (1997) Extensive Cellular Uptake into Endothelial Cells of an Amphipathic [beta]-Sheet Forming Peptide. FEBS Letters, 415, 196-199. https://doi.org/10.1016/S0014-5793(97)01123-X
|
[9]
|
Brock, R. (2014) The Uptake of Arginine-Rich Cell-Penetrating Peptides: Putting the Puzzle Together. Bioconjugate Chemistry, 25, 863-868. https://doi.org/10.1021/bc500017t
|
[10]
|
Shin, M.C., Zhang, J., Min, K.A., et al. (2014) Cell-Penetrating Peptides: Achievements and Challenges in Application for Cancer Treatment. Journal of Biomedical Materials Research Part A, 102, 575-587.
https://doi.org/10.1002/jbm.a.34859
|
[11]
|
Pouny, Y., Rapaport, D., Mor, A., et al. (1992) Interaction of Antimicrobial Dermaseptin and Its Fluorescently Labeled Analogues with Phospholipid Membranes. Biochemistry, 31, 12416-12423. https://doi.org/10.1021/bi00164a017
|
[12]
|
Matsuzaki, K. (1999) Why and How Are Peptide-Lipid Interactions Utilized for Self-Defense? Magainins and Tachyplesins as Archetypes. Biochimica et Biophysica Acta (BBA)—Biomembranes, 1462, 1-10.
https://doi.org/10.1016/S0005-2736(99)00197-2
|
[13]
|
Ludtke, S., He, K. and Huang, H. (1995) Membrane Thinning Caused by Magainin 2. Biochemistry, 34, 16764-16769.
https://doi.org/10.1021/bi00051a026
|
[14]
|
Palm-Apergi, C., Lorents, A., Padari, K., et al. (2009) The Membrane Repair Response Masks Membrane Disturbances Caused by Cell-Penetrating Peptide Uptake. FASEB Journal, 23, 214-223. https://doi.org/10.1096/fj.08-110254
|
[15]
|
Vives, E., Granier, C., Prevot, P., et al. (1997) Structure-Activity Relationship Study of the Plasma Membrane Translocating Potential of a Short Peptide from HIV-1 Tat Protein. Letters in Peptide Science, 4, 429-436.
https://doi.org/10.1023/A:1008850300184
|
[16]
|
Lundberg, M. and Johansson, M. (2002) Positively Charged DNA-Binding Proteins Cause Apparent Cell Membrane Translocation. Biochemical and Biophysical Research Communications, 291, 367-371.
https://doi.org/10.1006/bbrc.2002.6450
|
[17]
|
Richard, J.P., Melikov, K., Vives, E., et al. (2003) Cellpenetrating Peptides. A Reevaluation of the Mechanism of Cellular Uptake. The Journal of Biological Chemistry, 278, 585-590. https://doi.org/10.1074/jbc.M209548200
|
[18]
|
Wadia, J.S., Stan, R.V. and Dowdy, S.F. (2004) Transducible TAT-HA Fusogenic Peptide Enhances Escape of TAT-Fusion Proteins after Lipid Raft Macropinocytosis. Nature Medicine, 10, 310-315. https://doi.org/10.1038/nm996
|
[19]
|
Conner, S.D. and Schmid, S.L. (2003) Regulated Portals of Entry into the Cell. Nature, 422, 37-44.
https://doi.org/10.1038/nature01451
|
[20]
|
Maiolo, J.R., Ferrer, M. and Ottinger, E.A. (2005) Effects of Cargo Molecules on the Cellular Uptake of Arginine-Rich Cell-Penetrating Peptides. Biochimica et Biophysica Acta, 1712, 161-172.
https://doi.org/10.1016/j.bbamem.2005.04.010
|
[21]
|
Dubikovskaya, E.A., Thorne, S.H., Pillow, T.H., et al. (2008) Overcoming Multidrug Resistance of Small-Molecule Therapeutics through Conjugation with Releasable Octaarginine Transporters. Proceedings of the National Academy of Sciences of the United States of America, 105, 12128-12133. https://doi.org/10.1073/pnas.0805374105
|
[22]
|
Lee, J.Y., Choi, Y.S., Suh, J.S., et al. (2011) Cell-Penetrating Chi-tosan/Doxorubicin/TAT Conjugates for Efficient Cancer Therapy. International Journal of Cancer, 128, 2470-2480. https://doi.org/10.1002/ijc.25578
|
[23]
|
Hollstein, M., Sidransky, D., Vogelstein, B., et al. (1991) p53 Mutations in Human Cancers. Science, 253, 49-53.
https://doi.org/10.1126/science.1905840
|
[24]
|
Liggett, W.H. and Sidransky, D. (1998) Role of the p16 Tumor Suppressor Gene in Cancer. Journal of Clinical Oncology, 16, 1197-1206. https://doi.org/10.1200/JCO.1998.16.3.1197
|
[25]
|
Snyder, E.L., Meade, B.R., Saenz, C.C., et al. (2004) Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide. PLOS Biology, 2, E36. https://doi.org/10.1371/journal.pbio.0020036
|
[26]
|
Hosotani, R., Miyamoto, Y., Fujimoto, K., et al. (2002) Trojan p16 Peptide Suppresses Pancreatic Cancer Growth and Prolongs Survival in Mice. Clinical Cancer Research, 8, 1271-1276.
|
[27]
|
Vucic, D., Deshayes, K., Ackerly, H., et al. (2002) SMAC Negatively Regulates the Anti-Apoptotic Activity of Melanoma Inhibitor of Apoptosis (MLIAP). The Journal of Biological Chemistry, 277, 12275-12279.
https://doi.org/10.1074/jbc.M112045200
|
[28]
|
Fulda, S., Wick, W., Weller, M., et al. (2002) Smac Agonists Sensitize for Apo2L/TRAIL- or Anticancer Drug-Induced Apoptosis and Induce Regression of Malignant Glioma in Vivo. Nature Medicine, 8, 808-815.
https://doi.org/10.1038/nm735
|
[29]
|
Stirpe, F., Olsnes, S. and Pihl, A. (1980) Gelonin, a New Inhibitor of Protein Synthesis, Nontoxic to Intact Cells. Isolation, Characterization, and Preparation of Cytotoxic Complexes with Concanavalin A. The Journal of Biological Chemistry, 255, 6947-6953.
|
[30]
|
Park, Y.J., Chang, L.C., Liang, J.F., et al. (2005) Nontoxic Membrane Translocation Peptide from Protamine, Low Molecular Weight Protamine (LMWP), for Enhanced Intracellular Protein Delivery: In Vitro and In Vivo Study. THE FASEB Journal, 19, 1555-1557. https://doi.org/10.1096/fj.04-2322fje
|
[31]
|
Lu, P.Y., Xie, F.Y. and Woodle, M.C. (2003) siRNA-Mediated Antitumorigenesis for Drug Target Validation and Therapeutics. Current Opinion in Molecular Therapeutics, 5, 225-234.
|
[32]
|
Kim, W.J., Christensen, L.V., Jo, S., et al. (2006) Cholesteryl Oligoarginine Delivering Vascular Endothelial Growth Factor siRNA Effectively Inhibits Tumor Growth in Colon Adenocarcinoma. Molecular Therapy, 14, 343-350.
https://doi.org/10.1016/j.ymthe.2006.03.022
|
[33]
|
Crombez, L., Morris, M.C., Dufort, S., et al. (2009) Targeting Cyclin B1 through Peptide-Based Delivery of siRNA Prevents Tumour Growth. Nucleic Acids Research, 37, 4559-4569. https://doi.org/10.1093/nar/gkp451
|
[34]
|
Josephson, L., Tung, C.H., Moore, A., et al. (1999) High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates. Bioconjugate Chemistry, 10, 186-191. https://doi.org/10.1021/bc980125h
|
[35]
|
Torchilin, V.P. (2008) Cell Penetrating Peptide-Modified Pharmaceutical Nanocarriers for Intracellular Drug and Gene Delivery. Biopolymers, 90, 604-610. https://doi.org/10.1002/bip.20989
|
[36]
|
Balzeau, J., Pinier, M., Berges, R., et al. (2013) The Effect of Functionalizing Lipid Nanocapsules with NFL-TBS. 40-63 Peptide on Their Uptake by Glioblastoma Cells. Biomaterials, 34, 3381-3389.
https://doi.org/10.1016/j.biomaterials.2013.01.068
|
[37]
|
郝萧. 红鳍东方鲀重编程因子Oct4和Sox2原核表达载体的构建、精巢细胞原核表达产物的导入及其检测研究[D]: [硕士学位论文]. 青岛: 中国海洋大学海洋生命学院, 2011.
|
[38]
|
伟一凡. 细胞穿膜肽在藻类细胞外源物质转导中的应用[D]: [硕士学位论文]. 青岛: 中国科学院海洋研究所, 2014.
|
[39]
|
伟一凡, 郇丽, 等. 细胞穿膜肽转导大型海藻及对其光合作用的影响[J]. 海洋与湖沼, 2015, 46(5): 1235-1240.
|
[40]
|
Sun, Y. and Hu, Y.H. (2015) Cell-Penetrating Peptide-Mediated Subunit Vaccine Generates a Potent Immune and Protection against Streptococcus iniae in Japanese Flounder (Paralichthys olivaceus). Veterinary Immunology and Immunopathology, 167, 96-103. https://doi.org/10.1016/j.vetimm.2015.07.008
|
[41]
|
Ma, J., Xu, J., Guan, L., et al. (2014) Cell-Penetrating Peptides Mediated Protein Cross-Membrane Delivery and Its Use in Bacterial Vector Vaccine. Fish and Shellfish Immunology, 39, 8-16. https://doi.org/10.1016/j.fsi.2014.04.003
|
[42]
|
宫春爱, 胡楚玲, 等. 细胞穿膜肽在抗肿瘤靶向治疗中的研究进展[J]. 第二军医大学学报, 2017, 38(6): 774-779.
|